Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Medicortex International

0.89 SEK-3.05 %20/11 17:29
Less than 1K followers

MEDFIN B

NGM Growth Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-3.05 %
-23.28 %
-24.89 %
-67.04 %
-72.70 %
-72.95 %
-95.65 %
-99.21 %
-99.45 %

Medicortex International is a medical technology company that develops diagnostic solutions for traumatic brain injuries, with a focus on biomarker-based tests. The company conducts research and development with the goal of enabling rapid and accessible diagnostics and works long-term with the development of treatment solutions. The business has an international focus.

Read more
Market cap
27.57M SEK
Turnover
13.71K SEK
Revenue
4.98M
EBIT %
-117.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Forum discussions
Want more examples? During my 25-30 year investing career, especially regarding IPOs (and even more so crowdfunding), I’ve noticed that a company that doesn’t communicate is usually a bad investment. Fortunately, I’ve only had a few grand in these, max €5k. Medicortex and Fifax are...
5/10/2023, 8:37 PM
by Eskimo68
3
The company ended up listing on the Swedish stock exchange at the beginning of the month via a reverse takeover. I couldn’t find a press release, but news articles touched on the matter. Apparently, the company is now officially Swedish, so buying shares from Finland is also possible...
7/20/2026, 7:14 AM
by Szanne
2
Another share issue underway; they are planning (again) to list on First North. Interesting, I can’t even find information on whether the previous issue was successful and if more funding was secured from Business Finland. Maybe it was mentioned at the AGM, but I wasn’t particularly...
8/6/2024, 1:13 PM
by Eskimo68
1
Been waiting to be able to sell those. I was planning to dump a bigger chunk at the bid back in June, but that was never possible. I do notice that you could trade Medicortex International, but I have a big pile of those “previous” Medicortex Finlands… (which were supposed to be ...
10/17/2026, 2:29 PM
by Eskimo68
0
I attended the 2026 annual general meeting. Nothing particularly noteworthy, essentially, they’re awaiting Nosium’s Reverse TakeOver. I expressed a dissenting opinion on the board’s “giant compensation packages,” especially considering the company’s continuous positive results . ...
3/31/2026, 11:38 AM
by Eskimo68
0
They have another share issue underway right now at a price of €1, so in that sense, the share value is theoretically increasing. Once again, information is far too scarce. If there were at least some kind of shareholder list available so we knew who has invested in the company, ...
1/24/2024, 5:16 PM
by Eskimo68
0
They managed to raise 110k€ by the end of May. That’s presumably a fairly good amount already. Now, if I only had the energy to dig into how much the company spends each month, which is of course difficult because part of it probably comes from the DoD’s pot. Then when you add “new...
6/8/2023, 5:08 PM
by Eskimo68
0
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19/2
2027

Annual report '26

Regulatory press release2026-10-19 09:20

Medicortex International offentliggör bolagspresentation

Medicortex International
Regulatory press release2026-10-19 09:20

Medicortex International publishes company presentation

Medicortex International
Regulatory press release2026-09-28 14:25

Medicortex vd Adrian Harel: ”Vårt mål är ett test för hjärnskador som fungerar var som helst, för alla, på några minuter”

Medicortex International

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release2026-09-28 14:25

Medicortex CEO Adrian Harel: “Our goal is a brain injury test that works anywhere, for anyone, in minutes”

Medicortex International
Regulatory press release2026-09-01 13:48

Medicortex International AB (publ) ingår avtal inför riktade kvittningsemissioner om totalt cirka 9,9 MSEK

Medicortex International
Regulatory press release2026-09-01 13:48

Medicortex International AB (publ) enters into agreements ahead of planned directed set-off share issues totalling approximately SEK 9.9 million

Medicortex International
Regulatory press release2026-08-31 16:37

Medicortex International AB (publ) publishes interim report for the period April–June 2026

Medicortex International
Regulatory press release2026-08-31 16:37

Medicortex International AB (publ) offentliggör delårsrapport för perioden april–juni 2026

Medicortex International
Regulatory press release2026-08-28 17:00

Medicortex International AB (publ): Delårsrapporten för andra kvartalet 2026 publiceras den 31 augusti 2026

Medicortex International
Regulatory press release2026-08-28 16:58

Medicortex International AB (publ): Interim Report for the Second Quarter of 2026 to be Published on 31 August 2026

Medicortex International
Regulatory press release2026-08-20 13:10

A New Chapter for Medicortex International – From Scientific Innovation to Commercial Execution

Medicortex International
Press release2026-08-11 09:00

Shareholder Update – August 2026

Medicortex International
Regulatory press release2026-07-06 09:05

CEO Letter: Leading the Future of Brain Injury Diagnostics

Medicortex International
Regulatory press release2026-06-30 18:10

Medicortex International: förvärvet slutfört, NGM-villkor uppfyllda, Adrian Harel ny VD

Medicortex International
Regulatory press release2026-06-30 14:04

Kommuniké från årsstämma i Medicortex International AB (publ) den 30 juni 2026

Medicortex International
Regulatory press release2026-06-30 11:38

NOSIUM byter namn till Medicortex International AB (publ) – registrerat hos Bolagsverket

Medicortex International
Regulatory press release2026-06-18 12:05

NOSIUM AB (publ)har erhållit villkorat godkännande för fortsatt notering på NGM Growth Market

Medicortex International
Regulatory press release2026-06-05 16:30

RÄTTELSE: NOSIUM AB (publ) publicerar komplett årsredovisning för 2025 inklusive revisionsberättelse

Medicortex International
Regulatory press release2026-06-05 14:00

NOSIUM AB (publ) publicerar årsredovisning för 2025 och uppdaterar kring processen med Medicortex

Medicortex International
Regulatory press release2026-06-02 08:30

KALLELSE TILL ÅRSSTÄMMA I NOSIUM AB (PUBL)

Medicortex International